Last updated 2026-06-18
- Acquired by BiomX, Dec 2017
- Raised $2.5M funding round, Mar 2016
Total raised
$2.5M
Last: 2016-03
Stage
Acquired
Founded
2015
Headcount
1-10
HQ
Ramat HaSharon, Israel
Sector
Health Tech & Life Sciences
About
RondinX is building a target and drug discovery platform designed to create solutions in the microbiome therapeutic and companion diagnostic spaces. RondinX's core technology is a peak-to-trough family of algorithms exclusively licensed from YEDA, the commercial arm of the Weizmann Institute of Science. The proprietary, cloud-based computational pipeline uses raw metagenomics to derive both static and dynamic strain-level insights into the bacterial ecosystem.
Funding history · 1 round · $2.5M total
2016-03
$2.5M
Q&A
- What is RondinX's primary focus?
- RondinX is building a target and drug discovery platform focused on creating solutions in the microbiome therapeutic and companion diagnostic spaces.
- When was RondinX founded?
- RondinX was founded in May 2015.
- What is the status of RondinX?
- RondinX is currently active but was acquired by BiomX in December 2017.
- What is RondinX's core technology?
- RondinX's core technology is a peak-to-trough family of algorithms exclusively licensed from YEDA, the commercial arm of the Weizmann Institute of Science.
- How does RondinX's computational pipeline work?
- RondinX's proprietary, cloud-based computational pipeline uses raw metagenomics to derive both static and dynamic strain-level insights into the bacterial ecosystem.
- How much funding has RondinX raised in total?
- RondinX has raised a total of $2,500,000.
- Which investors participated in RondinX's funding round?
- In March 2016, RondinX raised $2,500,000 from investors including Elevator Fund and 8VC.
- What is the estimated employee count for RondinX?
- RondinX has an estimated employee count in the 1-10 range.
Team · 3
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMicroorganisms
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 PatentsVerified
Tags
microbiologygenomicsbiotechnologybioinformaticsbacteriamicrobiomenovel-ingredientsprecision-medicinepharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/7972893 |
Identifiers & details
| Founded | 2015-5 |
|---|---|
| Status reason | Acquired (Inactive) by BiomX on Dec 2017 - closed due to acquisition |
Acquisitions & public offerings
Acquired by BiomX 2017-12